SLC46A2 antisense RNA 1 (SLC46A2-AS1)

SLC46A2-AS1 (SLC46A2 antisense RNA 1) is a non-coding antisense RNA gene, also referred to as AL139041.1[3]. Antisense RNAs are a class of long non-coding RNAs that are transcribed from the opposite strand of protein-coding genes and may regulate their expression by interacting with the corresponding sense mRNA. SLC46A2-AS1, specifically, does not encode a protein and its function remains functionally uncharacterized in the biomedical literature[3]. Generally, antisense RNAs have been shown in recent studies to act as *regulators of gene expression*, sometimes accelerating gene expression by assisting with the nuclear export of mRNAs, but roles can be context-specific and often remain speculative unless directly demonstrated for a specific antisense RNA[4]. SLC46A2-AS1 is not a canonical druggable target such as a receptor, enzyme, transporter, or transcription factor. Instead, it is an RNA molecule that may regulate the expression or function of the neighboring SLC46A2 gene, which IS a solute carrier/transporter with defined biological function and potential therapeutic implications[1][2]. However, SLC46A2-AS1 itself should not be considered a therapeutic target in drug discovery or pharmacology without further evidence. Summary: - SLC46A2-AS1 (AL139041.1) is a non-coding, antisense RNA gene. - It is not considered a receptor, transporter, or protein drug target. - Its function is not well-characterized, and it is not a therapeutic target. - The entry is most accurately described as a non-coding RNA gene, not a protein target[3][4].

Other names

AL139041.1